Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
N Engl J Med
    April 2021
  1. ECKARDT KU, Agarwal R, Aswad A, Awad A, et al
    Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021;384:1601-1612.
    >> Share

  2. CHERTOW GM, Pergola PE, Farag YMK, Agarwal R, et al
    Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
    N Engl J Med. 2021;384:1589-1600.
    >> Share

  3. LEVIN A
    Therapy for Anemia in Chronic Kidney Disease - New Interventions and New Questions.
    N Engl J Med. 2021;384:1657-1658.
    >> Share

    March 2021
  4. LOOKSTEIN RA, Haruguchi H, Holden A
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. Reply.
    N Engl J Med. 2021;384:1173-1174.
    >> Share

  5. PACKER D
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1173.
    >> Share

  6. MAYUMI T, Okano H
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172-1173.
    >> Share

  7. SWINNEN J
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172.
    >> Share

  8. DAVIDSON I
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1171-1172.
    >> Share

  9. BAKRIS GL, Agarwal R, Filippatos G
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;384:e42.
    >> Share

  10. MOURA-NETO JA, Ronco C
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    >> Share

  11. YOUNG MJ, Fuller PJ
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    >> Share

  12. EDWARDS NC, Ferro CJ, Townend JN
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    >> Share

  13. MAKEMBI AB, Mohamadou I, Galichon P
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    >> Share

  14. BAUMSTEIN D
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    >> Share

    January 2021
  15. HEERSPINK HJL, Langkilde AM, Wheeler DC
    Dapagliflozin in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;384:389-390.
    >> Share

  16. YASUDA H, Isobe S
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:389.
    >> Share

  17. VOGT L
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:388-389.
    >> Share

    December 2020
  18. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2020;383:2219-2229.
    >> Share

    November 2020
  19. BHATT DL, Szarek M, Pitt B, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030186.
    >> Share

    October 2020
  20. WALD R, Bagshaw SM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1797-1798.
    >> Share

  21. SU Y, Tu GW, Luo Z
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    >> Share

  22. LUIJNENBURG TWF, Petjak M, de Pont AJM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    >> Share

  23. BOUCHARD J, Cutter G, Mehta R
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1796.
    >> Share

  24. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    >> Share

  25. INGELFINGER JR, Rosen CJ
    Finerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
    N Engl J Med. 2020 Oct 23. doi: 10.1056/NEJMe2031382.
    >> Share

  26. FEIG DI
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1692.
    >> Share

  27. BADVE SV, Pascoe EM
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1691-1692.
    >> Share

  28. DORIA A, Galecki AT, Mauer M
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1690-1691.
    >> Share

  29. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    >> Share

  30. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    >> Share

  31. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    >> Share

  32. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    >> Share

  33. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    >> Share

    September 2020
  34. HEERSPINK HJL, Stefansson BV, Correa-Rotter R, Chertow GM, et al
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020 Sep 24. doi: 10.1056/NEJMoa2024816.
    >> Share

    August 2020
  35. LOOKSTEIN RA, Haruguchi H, Ouriel K, Weinberg I, et al
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2020;383:733-742.
    >> Share

    July 2020
  36. BAGSHAW SM, Wald R, Adhikari NKJ, Bellomo R, et al
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:240-251.
    >> Share


  37. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMx200016.
    >> Share

  38. KALANTAR-ZADEH K, Wightman A, Liao S
    Ensuring Choice for People with Kidney Failure - Dialysis, Supportive Care, and Hope.
    N Engl J Med. 2020;383:99.
    >> Share

  39. KAPLAN JM
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    >> Share

  40. XIE J, Chen N
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    >> Share

  41. SHAH HH, Fishbane S
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    >> Share

  42. MOHANDAS R, Segal MS
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    >> Share

  43. ZIELNIOK K, Burdzinska A, Paczek L
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    >> Share

  44. ANKER MS, Butler J, Anker SD
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    >> Share

  45. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    >> Share

    June 2020
  46. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    >> Share

  47. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    >> Share

  48. ANAND S, Staniec A, Montez-Rath M, Vlahos P, et al
    Using GIS Mapping to Track Hot Spots of Kidney Disease in California.
    N Engl J Med. 2020;382:2265-2267.
    >> Share

    May 2020
  49. FISHBANE S
    Difelikefalin in Hemodialysis Patients with Pruritus. Reply.
    N Engl J Med. 2020;382:2065-2066.
    >> Share

  50. LIN CH
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064-2065.
    >> Share

  51. MANENTI L, Rossi GM, Fiaccadori E
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    >> Share

  52. BRENNAN F, Davison S, Brown M
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    >> Share

    March 2020
  53. RAMON A, Berthod PE
    Osteitis Fibrosa Cystica.
    N Engl J Med. 2020;382:e15.
    >> Share

    February 2020
  54. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    >> Share

    January 2020
  55. BLASI M, Stadtler H, Chang J, Hemmersbach-Miller M, et al
    Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
    N Engl J Med. 2020;382:195-197.
    >> Share

    November 2019
  56. FISHBANE S, Jamal A, Munera C, Wen W, et al
    A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2019 Nov 8. doi: 10.1056/NEJMoa1912770.
    >> Share

    October 2019
  57. SELHORST P, Combrinck CE, Manning K, Botha FCJ, et al
    Longer-Term Outcomes of HIV-Positive-to-HIV-Positive Renal Transplantation.
    N Engl J Med. 2019;381:1387-1389.
    >> Share

    August 2019
  58. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities. Reply.
    N Engl J Med. 2019;381:689.
    >> Share

  59. VIOLO L, De Francesco M, Locatelli F
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688-689.
    >> Share

  60. CHANG KT, Lin HY
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688.
    >> Share

  61. BHOWMIK DM
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:687-688.
    >> Share

    July 2019
  62. CHEN N, Hao C, Liu BC, Lin H, et al
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1901713.
    >> Share

  63. CHEN N, Hao C, Peng X, Lin H, et al
    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1813599.
    >> Share

  64. KAPLAN J
    Roxadustat and Anemia of Chronic Kidney Disease.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMe1908978.
    >> Share

    June 2019
  65. MACDOUGALL IC, Ford I
    Intravenous Iron and Maintenance Hemodialysis. Reply.
    N Engl J Med. 2019;380:e46.
    >> Share

  66. AFSAR B, Elsurer Afsar R, Kanbay M
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    >> Share

  67. NAKANISHI T, Kuragano T
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    >> Share

  68. EISENGA MF, Bakker SJL, Gaillard CAJM
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    >> Share

  69. AGARWAL R
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    >> Share

    May 2019
  70. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;380:1843-1852.
    >> Share

    April 2019
  71. INGELFINGER JR, Rosen CJ
    Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMe1904740.
    >> Share

  72. PERKOVIC V, Jardine MJ, Neal B, Bompoint S, et al
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744.
    >> Share

  73. WOJCIECHOWSKI D, Gandhi RT, Rosales IA
    Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.
    N Engl J Med. 2019;380:1464-1472.
    >> Share

    January 2019

  74. Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-399.
    >> Share

  75. XUE C, Zhou C, Xue D
    Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-9.
    >> Share


  76. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2019 Jan 14. doi: 10.1056/NEJMx180044.
    >> Share

    October 2018
  77. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2018 Oct 26. doi: 10.1056/NEJMoa1810742.
    >> Share

  78. BARBAR SD, Clere-Jehl R, Bourredjem A, Hernu R, et al
    Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.
    N Engl J Med. 2018;379:1431-1442.
    >> Share

  79. CAULLEY L
    A Seat at the Table.
    N Engl J Med. 2018;379:1400-1401.
    >> Share

  80. BERNS JS, Glickman A, McCoy MS
    Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.
    N Engl J Med. 2018;379:1295-1297.
    >> Share

    August 2018
  81. MARTINS JM, Magrico R
    Uremic Frost in End-Stage Renal Disease.
    N Engl J Med. 2018;379:669.
    >> Share

    May 2018
  82. DELMONICO FL
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1.
    >> Share

  83. CASTELLANO G, Cravedi P
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    >> Share

  84. KALLEN R
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    >> Share


  85. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1752.
    >> Share

    February 2018
  86. BERNS JS
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:584.
    >> Share

  87. HOORN EJ, Vogt L, Rotmans JI
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-4.
    >> Share

  88. URIBARRI J
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583.
    >> Share


  89. Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-585.
    >> Share

  90. CALDERON-MARGALIT R, Golan E, Twig G, Leiba A, et al
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:428-438.
    >> Share

    December 2017
  91. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    >> Share

    November 2017
  92. TORRES VE, Chapman AB, Devuyst O, Gansevoort RT, et al
    Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
    N Engl J Med. 2017;377:1930-1942.
    >> Share

  93. KALANTAR-ZADEH K, Fouque D
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2017;377:1765-1776.
    >> Share

    October 2017
  94. SALY DL, Brewster UC, Sze GK, Louis ED, et al
    An Element of Unsteadiness.
    N Engl J Med. 2017;377:1379-1385.
    >> Share

    August 2017
  95. MANN JFE, Orsted DD, Brown-Frandsen K, Marso SP, et al
    Liraglutide and Renal Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:839-848.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016